Teva Generic Univasc Patent Victory Vacated
This article was originally published in The Pink Sheet Daily
Executive Summary
Teva plans to continue distributing its generic version of Schwarz' Univasc despite an appeals court's Jan. 29 opinion vacating a noninfringement ruling for the company